Ajooni Biotech Limited — Board Meeting, 13-02-2025: Outcome of Board Meeting

The Board of Directors of Ajooni Biotech Limited has approved the unaudited financial results for the quarter ended December 31, 2024. Total income from operations stood at ₹2,603.40 Cr, driven primarily by revenue from operations of ₹2,572.44 Cr. The company reported a profit before tax of ₹100.98 Cr, and a net profit of ₹73.02 Cr for the quarter. The results reflect positive trends in revenue growth, positioning the company to leverage future opportunities in the biotech sector.